Skip to main content
Top
Published in: International Journal of Hematology 2/2020

01-08-2020 | Herpes Virus | Case Report

Limbic encephalitis with antibodies to N-methyl-d-aspartate (NMDA)-type glutamate receptor after allogeneic transplantation

Authors: Jun Toda, Tetsuo Maeda, Keigo Akuta, Shinsuke Kusakabe, Tomoaki Ueda, Jiro Fujita, Hirohiko Shibayama, Kenji Oritani, Yukitoshi Takahashi, Yuzuru Kanakura

Published in: International Journal of Hematology | Issue 2/2020

Login to get access

Abstract

Various central nervous system (CNS) complications may occur after allogeneic hematopoietic stem cell transplantation (allo-HSCT), which can result in severe clinical problems. Diagnosis is often difficult, as distinctive clinical symptoms may be absent and different neurological disorders may exhibit similar symptoms. Despite the fact that antibodies responding to brain cell surface antigens have become well recognized in several CNS disorders, cases of autoimmune CNS disorders after allo-HSCT have rarely been reported. Here, we report on a patient who developed encephalitis associated with antibodies against N-methyl-d-aspartate (NMDA)-type glutamate receptor (GluR) after allo-HSCT. To the best of our knowledge, this is the first report of the involvement of antibodies against NMDA-type GluR in post-transplantation encephalitis. Autoimmunity to NMDA-type GluR may have contributed to neurological complications after transplantation in unresolved cases.
Literature
1.
go back to reference Maffini E, Festuccia M, Brunello L, Boccadoro M, Giaccone L, Bruno B. Neurologic complications after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2017;23:388–97.CrossRef Maffini E, Festuccia M, Brunello L, Boccadoro M, Giaccone L, Bruno B. Neurologic complications after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2017;23:388–97.CrossRef
2.
go back to reference Lin TA, Gau JP, Liu YC, Ko PS, Wang HY, Chien SH, et al. Cerebrovascular disease after allogeneic hematopoietic stem cell transplantation: incidence, risk, and clinical outcome. Int J Hematol. 2019;109:584–92.CrossRef Lin TA, Gau JP, Liu YC, Ko PS, Wang HY, Chien SH, et al. Cerebrovascular disease after allogeneic hematopoietic stem cell transplantation: incidence, risk, and clinical outcome. Int J Hematol. 2019;109:584–92.CrossRef
3.
go back to reference Rggiu M, Cuccuini W, Mokhtari K, Meignin V, Peffault de Latour R, Robin M, et al. Case report: central nervous system involvement of human graft versus host disease: report of 7 cases and a review of literature. Medicine (Baltimore). 2017;96(42):e8303.CrossRef Rggiu M, Cuccuini W, Mokhtari K, Meignin V, Peffault de Latour R, Robin M, et al. Case report: central nervous system involvement of human graft versus host disease: report of 7 cases and a review of literature. Medicine (Baltimore). 2017;96(42):e8303.CrossRef
4.
go back to reference Min GJ, Park S, Park SS, Yoon JH, Lee SE, Cho BS, et al. A case of central nervous system graft-versus-host disease following allogeneic stem cell transplantation. Int J Hematol. 2019;110:635–9.CrossRef Min GJ, Park S, Park SS, Yoon JH, Lee SE, Cho BS, et al. A case of central nervous system graft-versus-host disease following allogeneic stem cell transplantation. Int J Hematol. 2019;110:635–9.CrossRef
5.
go back to reference Dalmau J, Tüzün E, Wu HY, Masjuan J, Rossi JE, Voloschin A, et al. Paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61:25–36.CrossRef Dalmau J, Tüzün E, Wu HY, Masjuan J, Rossi JE, Voloschin A, et al. Paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61:25–36.CrossRef
6.
go back to reference Takahashi Y, Nishida T, Kimizu T, Oboshi T, Horino A, Koike T, et al. Autoimmune-mediated encephalitis with antibodies to NMDA-type GluRs: early clinical diagnosis. In: Yamanouchi H, Moshé S, Okumura A, Cross H, Galanopoulou AS, Dale R, et al., editors. Acute encephalopathy and encephalitis in infancy and its related disorders. St. Louis: Elsevier; 2017. p. 151–156. Takahashi Y, Nishida T, Kimizu T, Oboshi T, Horino A, Koike T, et al. Autoimmune-mediated encephalitis with antibodies to NMDA-type GluRs: early clinical diagnosis. In: Yamanouchi H, Moshé S, Okumura A, Cross H, Galanopoulou AS, Dale R, et al., editors. Acute encephalopathy and encephalitis in infancy and its related disorders. St. Louis: Elsevier; 2017. p. 151–156.
7.
go back to reference Takahashi Y, Mori H, Mishina M, Watanabe M, Kondo N, Shimomura J, et al. Autoantibodies and cell-mediated autoimmunity to NMDA-type GluRepsilon2 in patients with Rasmussen’s encephalitis and chronic progressive epilepsia partialis continua. Epilepsia. 2005;46(Suppl 5):152–8.CrossRef Takahashi Y, Mori H, Mishina M, Watanabe M, Kondo N, Shimomura J, et al. Autoantibodies and cell-mediated autoimmunity to NMDA-type GluRepsilon2 in patients with Rasmussen’s encephalitis and chronic progressive epilepsia partialis continua. Epilepsia. 2005;46(Suppl 5):152–8.CrossRef
8.
go back to reference Fukuyama T, Takahashi Y, Kubota Y, Mogami Y, Imai K, Kondo Y, et al. Semi-quantitative analyses of antibodies to N-methyl-d-aspartate type glutamate receptor subunits (GluN2B & GluN1) in the clinical course of Rasmussen syndrome. Epilepsy Res. 2015;113:34–433.CrossRef Fukuyama T, Takahashi Y, Kubota Y, Mogami Y, Imai K, Kondo Y, et al. Semi-quantitative analyses of antibodies to N-methyl-d-aspartate type glutamate receptor subunits (GluN2B & GluN1) in the clinical course of Rasmussen syndrome. Epilepsy Res. 2015;113:34–433.CrossRef
9.
go back to reference Fujita K, Yuasa T, Takahashi Y, Tanaka K, Sako W, Koizumi H, et al. Antibodies to N-methyl-d-aspartate glutamate receptors in Creutzfeldt-Jakob disease patients. J Neuroimmunol. 2012;251:90–3.CrossRef Fujita K, Yuasa T, Takahashi Y, Tanaka K, Sako W, Koizumi H, et al. Antibodies to N-methyl-d-aspartate glutamate receptors in Creutzfeldt-Jakob disease patients. J Neuroimmunol. 2012;251:90–3.CrossRef
10.
go back to reference Ikura T, Katsuse O, Chiba Y, Takahashi Y, Fujishiro H, Kamada A, et al. Evaluation of titers of antibodies against peptides of subunits NR1 and NR2B of glutamate receptor by enzyme-linked immunosorbent assay in psychiatric patients with anti-thyroid antibodies. Neurosci Lett. 2016;628:201–6.CrossRef Ikura T, Katsuse O, Chiba Y, Takahashi Y, Fujishiro H, Kamada A, et al. Evaluation of titers of antibodies against peptides of subunits NR1 and NR2B of glutamate receptor by enzyme-linked immunosorbent assay in psychiatric patients with anti-thyroid antibodies. Neurosci Lett. 2016;628:201–6.CrossRef
11.
go back to reference Hayata Y, Hamada K, Sakurai Y, Sugimoto I, Mannen T, Takahashi Y. Anti-glutamate ε2 receptor antibody-positive and anti-N-methyl-d-aspartate receptor antibody-negative lobar encephalitis presenting as global aphasia and swallowing apraxia. Case Rep Neurol. 2014;6:291–6.CrossRef Hayata Y, Hamada K, Sakurai Y, Sugimoto I, Mannen T, Takahashi Y. Anti-glutamate ε2 receptor antibody-positive and anti-N-methyl-d-aspartate receptor antibody-negative lobar encephalitis presenting as global aphasia and swallowing apraxia. Case Rep Neurol. 2014;6:291–6.CrossRef
12.
go back to reference Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15:391–404.CrossRef Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15:391–404.CrossRef
13.
go back to reference Takahashi Y, Kimizu Y, Koike T, Horino A. Autoimmune mediated encephalitis/encephalopathy (in Japanese). Neurolog Ther. 2016;33:19–26. Takahashi Y, Kimizu Y, Koike T, Horino A. Autoimmune mediated encephalitis/encephalopathy (in Japanese). Neurolog Ther. 2016;33:19–26.
14.
go back to reference Nishiyama S, Ito T, Misu T, Takahashi T, Kikuchi A, Suzuki N, et al. A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset. Neurology. 2009;72:1960–1.CrossRef Nishiyama S, Ito T, Misu T, Takahashi T, Kikuchi A, Suzuki N, et al. A case of NMO seropositive for aquaporin-4 antibody more than 10 years before onset. Neurology. 2009;72:1960–1.CrossRef
15.
go back to reference Gresa-Arribas N, Titulaer MJ, Torrents A, Aguilar E, McCracken L, Leypoldt F, et al. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol. 2014;13:167–77.CrossRef Gresa-Arribas N, Titulaer MJ, Torrents A, Aguilar E, McCracken L, Leypoldt F, et al. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol. 2014;13:167–77.CrossRef
16.
go back to reference Hughes EG, Peng X, Gleichman AJ, Lai M, Zhou L, Tsou R, et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci. 2010;30:5866–75.CrossRef Hughes EG, Peng X, Gleichman AJ, Lai M, Zhou L, Tsou R, et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci. 2010;30:5866–75.CrossRef
17.
go back to reference Derksen SJ, Goraj B, Molenaar JG, van der Hoeven JG. Severe anti NMDA encephalitis and EBV infection. Neth J Crit Care. 2013;17:19–211. Derksen SJ, Goraj B, Molenaar JG, van der Hoeven JG. Severe anti NMDA encephalitis and EBV infection. Neth J Crit Care. 2013;17:19–211.
18.
go back to reference Zhao CZ, Erickson J, Dalmau J. Clinical reasoning: agitation and psychosis in a patient after renal transplantation. Neurology. 2012;79:e41–44.CrossRef Zhao CZ, Erickson J, Dalmau J. Clinical reasoning: agitation and psychosis in a patient after renal transplantation. Neurology. 2012;79:e41–44.CrossRef
19.
go back to reference Randall A, Saif H, Anu J, Larner AJ. Autoimmune encephalitis (NMDAR antibody) in a patient receiving chronic post-transplant immunosuppression. Pract Neurol. 2018;18:320–2.CrossRef Randall A, Saif H, Anu J, Larner AJ. Autoimmune encephalitis (NMDAR antibody) in a patient receiving chronic post-transplant immunosuppression. Pract Neurol. 2018;18:320–2.CrossRef
20.
go back to reference Cohen DA, Lopez-Chiriboga AS, Pittock SJ, Gadoth A, Zekeridou A, Boilson BA, et al. Posttransplant autoimmune encephalitis. Neurol Neuroimmunol Neuroinflamm. 2018;5:e497.CrossRef Cohen DA, Lopez-Chiriboga AS, Pittock SJ, Gadoth A, Zekeridou A, Boilson BA, et al. Posttransplant autoimmune encephalitis. Neurol Neuroimmunol Neuroinflamm. 2018;5:e497.CrossRef
21.
go back to reference Garré J, Sprengers M, Van Melkebeke D, Laureys G. EBV-NMDA double positive encephalitis in an immunocompromised patient. J Neurol Sci. 2019;396:76–7.CrossRef Garré J, Sprengers M, Van Melkebeke D, Laureys G. EBV-NMDA double positive encephalitis in an immunocompromised patient. J Neurol Sci. 2019;396:76–7.CrossRef
22.
go back to reference Konen FF, Schwenkenbecher P, Jendretzky KF, Hümmert MW, Wegner F, Stangel M, et al. Severe anti-N-methyl-d-aspartate receptor encephalitis under immunosuppression after liver transplantation. Front Neurol. 2019;10:987.CrossRef Konen FF, Schwenkenbecher P, Jendretzky KF, Hümmert MW, Wegner F, Stangel M, et al. Severe anti-N-methyl-d-aspartate receptor encephalitis under immunosuppression after liver transplantation. Front Neurol. 2019;10:987.CrossRef
23.
go back to reference Matà S, Muscas GC, Naldi I, Rosati E, Paladini S, Cruciatti B, et al. Non-paraneoplastic limbic encephalitis associated with anti-glutamic acid decarboxylase antibodies. J Neuroimmunol. 2008;199:155–9.CrossRef Matà S, Muscas GC, Naldi I, Rosati E, Paladini S, Cruciatti B, et al. Non-paraneoplastic limbic encephalitis associated with anti-glutamic acid decarboxylase antibodies. J Neuroimmunol. 2008;199:155–9.CrossRef
24.
go back to reference Niehusmann P, Mittelstaedt T, Bien CG, Drexler JF, Grote A, Schoch S, et al. Presence of human herpes virus 6 DNA exclusively in temporal lobe epilepsy brain tissue of patients with history of encephalitis. Epilepsia. 2010;51:2478–83.CrossRef Niehusmann P, Mittelstaedt T, Bien CG, Drexler JF, Grote A, Schoch S, et al. Presence of human herpes virus 6 DNA exclusively in temporal lobe epilepsy brain tissue of patients with history of encephalitis. Epilepsia. 2010;51:2478–83.CrossRef
25.
go back to reference Niehusmann P, Widman G, Eis-Hübinger AM, Greschus S, Robens BK, Grote A, et al. Non-paraneoplastic limbic encephalitis and central nervous HHV-6B reactivation: causality or coincidence? Neuropathology. 2016;36:376–80.CrossRef Niehusmann P, Widman G, Eis-Hübinger AM, Greschus S, Robens BK, Grote A, et al. Non-paraneoplastic limbic encephalitis and central nervous HHV-6B reactivation: causality or coincidence? Neuropathology. 2016;36:376–80.CrossRef
26.
go back to reference Linnoila JJ, Binnicker MJ, Majed M, Klein CJ, McKeon A. CSF herpes virus and autoantibody profiles in the evaluation of encephalitis. Neurol Neuroimmunol Neuroinflamm. 2016;3:e245.CrossRef Linnoila JJ, Binnicker MJ, Majed M, Klein CJ, McKeon A. CSF herpes virus and autoantibody profiles in the evaluation of encephalitis. Neurol Neuroimmunol Neuroinflamm. 2016;3:e245.CrossRef
27.
go back to reference Broccolo F, Fusetti L, Ceccherini-Nelli L. Possible role of human herpesvirus 6 as a trigger of autoimmune disease. Sci World J. 2013;2013:867389.CrossRef Broccolo F, Fusetti L, Ceccherini-Nelli L. Possible role of human herpesvirus 6 as a trigger of autoimmune disease. Sci World J. 2013;2013:867389.CrossRef
Metadata
Title
Limbic encephalitis with antibodies to N-methyl-d-aspartate (NMDA)-type glutamate receptor after allogeneic transplantation
Authors
Jun Toda
Tetsuo Maeda
Keigo Akuta
Shinsuke Kusakabe
Tomoaki Ueda
Jiro Fujita
Hirohiko Shibayama
Kenji Oritani
Yukitoshi Takahashi
Yuzuru Kanakura
Publication date
01-08-2020
Publisher
Springer Singapore
Published in
International Journal of Hematology / Issue 2/2020
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-020-02859-0

Other articles of this Issue 2/2020

International Journal of Hematology 2/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine